R9K (p.Arg9Lys) variant of NAT2 (Arylamine N-acetyltransferase 2)
R9K (p.Arg9Lys) in NAT2 (Arylamine N-acetyltransferase 2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
R9K (p.Arg9Lys) variant details
- p.Arg9Lys
- NCI-TCGA Cosmic COSV5406
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available